Table: Brightpath Biotherapeutics - 6-MTH parent results

BrightPath Biotherapeutics Co

13/11/2020 06:00

Nov 13 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2020        Sep 30, 2019      Mar 31, 2021  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             1 mln               1 mln             3 mln     
                 (-27.5 pct)                           (-73.5 pct)  
  Operating     loss 772 mln        loss 843 mln        loss 1.89   
  Recurring     loss 777 mln        loss 841 mln        loss 1.89   
  Net           loss 774 mln        loss 837 mln        loss 1.91   
  EPS          loss 17.05 yen      loss 19.94 yen    loss 45.30 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T